Testosterone in prostate cancer: the Bethesda consensus.

Testosterone in prostate cancer: the Bethesda consensus.

Item
http://www.wikidata.org/entity/Q37963010
Hormone naïve prostate cancer: predicting and maximizing response intervalsMaximal testosterone suppression in prostate cancer--free vs total testosteroneRed wine and component flavonoids inhibit UGT2B17 in vitro.Defining a new testosterone threshold for medical castration: Results from a prospective cohort series.Inadequate testosterone suppression after medical and subsequent surgical castration in a patient with prostate cancer.Intramuscular depot formulations of leuprolide acetate suppress testosterone levels below a 20 ng/dL threshold: a retrospective analysis of two Phase III studies.Free Testosterone During Androgen Deprivation Therapy Predicts Castration-Resistant Progression Better Than Total Testosterone.Effectiveness of Subcutaneously Administered Leuprolide Acetate to Achieve Low Nadir Testosterone in Prostate Cancer Patients
P2860

Testosterone in prostate cancer: the Bethesda consensus.

Item
http://www.wikidata.org/entity/Q37963010
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Testosterone in prostate cancer: the Bethesda consensus.
@en
Testosterone in prostate cancer: the Bethesda consensus.
@nl
type
label
Testosterone in prostate cancer: the Bethesda consensus.
@en
Testosterone in prostate cancer: the Bethesda consensus.
@nl
prefLabel
Testosterone in prostate cancer: the Bethesda consensus.
@en
Testosterone in prostate cancer: the Bethesda consensus.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Testosterone in prostate cancer: the Bethesda consensus.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1464-410X.2011.10719.X
P433
P478
P577
P698